Clinical Trial Update: INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for INCMGA00012 in previously treated unresectable or metastatic adenosquamous pancreatic or ampullary cancer (NCT04116073). The trial has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Cancer
• Pancreatic Cancer

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2025-07-29